AUS
NZ
UK
CA
USA
IND
Healthcare
Orthocell Stock Up 356% On The Clinical Response Of CelGro®
May 08, 2019 08:44 PM AEST| By Team Kalkine MediaOrthocell Limited (ASX: OCC) is a pharmaceutical company based in Australia. The company specialises in regenerative medicine, regeneration of tissue and restoring mobility, offering new techniques to the regeneration of tendon, repair, soft tissue i...
Paradigm Reports Significant Reductions In BML In Various Body Sites
May 08, 2019 05:12 PM AEST| By Team Kalkine MediaParadigm Biopharmaceuticals Ltd (ASX: PAR) is an ASX listed healthcare company, focusing on repurposing pentosan polysulphate sodium (PPS) for the treatment of medical conditions that have an active role in inflammation. The important properties of t...
HeraMed partners with Turkey-based Medizane; broadens European Distribution network
May 08, 2019 04:06 PM AEST| By Team Kalkine MediaHeraMed Limited (ASX: HMD), established in 2011 and based out of West Perth, is a medical technology company that develops and sells pregnancy monitoring solutions for home and professional use for patients in Europe, Israel and Australia. Currently,...
MGC Pharma Receives First Shipment Of CannEpil™ In The UK; Stock Up 16%!
May 07, 2019 08:49 PM AEST| By Team Kalkine MediaMGC Pharmaceuticals Ltd (ASX: MXC), a leading cannabinoid bio-pharma company, is involved in delivering high-quality cannabinoids based pharmaceuticals products to markets of Australasia, Europe and North America. The company announced today that th...
MedAdvisor Sets Up ZPM, A New JV With Zuellig Pharma
May 07, 2019 08:04 PM AEST| By Team Kalkine MediaMedAdvisor Limited (ASX: MDR) is a health care company based in Camberwell, Australia. The company provides a medication management platform to aid people in making the best use of medicines. The company?s mobile and web apps are easy to use and simp...
CannPal Announces Phase 1 Results For Its Lead Drug Candidate CPAT-01
May 07, 2019 07:50 PM AEST| By Team Kalkine MediaCannPal Animal Therapeutics Limited (ASX: CP1), a pharmaceutical company focused on products for veterinary therapeutics derived from cannabis. CannPal is developing and researching therapeutics for veterinarians derived from cannabinoids for the tre...
Actinogen Medical Released Alzheimer’s Disease Trial
May 07, 2019 02:51 PM AEST| By Team Kalkine MediaBiotechnology company Actinogen Medical Limited?s (ASX: ACW) lead compound Xanamem has failed to demonstrate adequate efficacy in improving cognition in mild Alzheimer?s disease. In an update provided on 7 May 2019, the company announced the results...
PharmAust Receives Positive Results from Ongoing Phase I Trial Program
May 07, 2019 12:29 PM AEST| By Team Kalkine MediaPharmAust Limited (ASX: PAA) is a clinical-stage company, developing targeted cancer therapeutics to address both humans as well as animal healthcare. On 7th February 2019, PharmAust Limited entered into an agreement with US Contract Research Organi...
KZA Announces Superior Safety and Tolerability Data From GDC-0084’s Phase IIa Study
May 06, 2019 09:36 PM AEST| By Team Kalkine MediaKazia Therapeutics Limited (ASX: KZA) is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. On 6th May 2019, Kazia Therapeutics Limited announced new safety data from its ongoing Phase IIa study of GDC-0084 in the new...
MGC Pharma Announces Partnership with Grow Biotech and IPS
May 06, 2019 03:26 PM AEST| By Team Kalkine MediaAn EU-based BioPharma company, MGC Pharmaceuticals Ltd (ASX: MXC) is an expert in the medical cannabis industry. The company?s strategy is to deliver high-quality cannabinoids-based pharmaceuticals products in the European, North American and Austral...
A Look At Healthcare Stock - VHT
May 05, 2019 08:00 AM AEST| By Team Kalkine MediaVolpara Health Technologies Limited (ASX: VHT) is a health sector company of New Zealand and a leading provider of breast imaging analytics and analysis products that deliver personalised breast cancer screening software applications. The AI imaging...
How Are Investor’s Eyeing These Healthcare Stocks – CSL, RMD, COH, NAN
May 04, 2019 08:00 AM AEST| By Team Kalkine MediaCSL Limited (ASX: CSL) CSL Limited (ASX: CSL) is engaged in the business of biopharmaceutical and allied products with R&D, manufacturing, marketing and distribution. Basically, the group operates through two segments ? (1) CSL Behring: focuses...
Noxopharm Advances One-Step up on Its Cancer Management Program
May 03, 2019 07:00 PM AEST| By Team Kalkine MediaUnearthing the long-lasting responses with Veyonda? in the treatment of prostate cancer Clinical-stage drug development company, Noxopharm Limited (ASX: NOX) lately announced the 6-month interim results from the dose-escalation arm of the DARRT-1 st...
Favourable for IPD: ASBrS Releases PREVENT Abstract; BIS Found Effective
May 03, 2019 04:42 PM AEST| By Team Kalkine MediaImpediMed Limited (ASX: IPD) is engaged in the business of production and designing of medical devices with BIS (Bioimpedance Spectroscopy) technologies to non-invasively measure, manage and monitor tissue composition and fluid status. The company to...
Respiri to Enter Indian Market; Announces JV with MedAchievers Private Limited
May 03, 2019 04:17 PM AEST| By Team Kalkine MediaToday, on 3rd May 2019, Respiri Limited (ASX: RSH) announces a Joint Venture Agreement for the company?s entry into India with MedAchievers Private Limited, which is an integrated platform for global healthcare, led by Dr Harsha Vardhan, Founder and...
Healthcare Company, PolyNovo Achieved Its First Million-Dollar Month
May 03, 2019 04:08 PM AEST| By Team Kalkine MediaPolyNovo Limited (ASX: PNV) is an ASX listed healthcare company based in Melbourne, Australia. The company specialises in developing and manufacturing unique biodegradable polymers which are used in medical devices. Biodegradable Temporising Matrix (...
ResMed Shares Skyrocketed On Solid Quarterly Results For Q3 FY19
May 03, 2019 02:06 PM AEST| By Team Kalkine MediaResMed Inc.(NYSE: RMD, ASX: RMD) shares surged up over 9% in mid-day trade after the company announced 12% year-over-year growth in its revenue for the third quarter of Fiscal Year 2019. The stock is trading at $16.210, up 9.527%, as at 3 May 2019 (1...
Anteo’s Battery & Life Sciences Division Making Excellent Progress With AnteoCoat™ And AnteoBind™
May 03, 2019 01:08 PM AEST| By Team Kalkine MediaAnteo Diagnostics Limited (ASX: ADO), a company from the Health Care sector that is into the business of Developing and commercializing medical products provided an update on commercial engagements in the Battery and Life Sciences division. The comp...
MGC Pharmaceuticals Signed Two Agreements With Health House And Cannvalate
May 03, 2019 01:04 PM AEST| By Team Kalkine MediaMGC Pharmaceuticals Ltd (ASX: MXC) is an ASX listed healthcare company based in Europe. The company has vast experience in the biopharma industry. Its primary business strategy is to develop and supply high-quality cannabinoid-based pharmaceuticals p...
AdAlta Announces Completion of Confirmation Run for Manufacturing of AD-214
May 02, 2019 02:00 PM AEST| By Team Kalkine MediaToday, on 2nd May 2019, the biotechnology company AdAlta Limited (ASX: 1AD) announced that it is well on track with the development of AD-214 (a lead program) for Idiopathic Pulmonary Fibrosis, following the successful completion of a confirmation ru...
Advertise your brand on Kalkine Media